These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The immune response and cancer. A guide. Gilbert HA; Kagan AR Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271 [No Abstract] [Full Text] [Related]
24. Immunology and malignant disease. Klein E; Cochran AJ Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507 [No Abstract] [Full Text] [Related]
25. [Limits and possibilities of neoplasm immunotherapy]. Kurth R Naturwissenschaften; 1978 Apr; 65(4):180-7. PubMed ID: 78457 [TBL] [Abstract][Full Text] [Related]
26. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas. Lee Y; Bigner DD Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of immunity in cancer. Baldwin RW Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216 [No Abstract] [Full Text] [Related]
28. Immunology of sarcomas. Mitchell MS Clin Orthop Relat Res; 1980; (153):26-30. PubMed ID: 6160937 [TBL] [Abstract][Full Text] [Related]
29. The role of immunology in the diagnosis and treatment of cancer. Humphrey LJ; Pierce GE Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858 [No Abstract] [Full Text] [Related]
30. [Introduction to the International Symposium on Tumor Immunotherapy]. De Barbieri A Boll Ist Sieroter Milan; 1971; 50(3):137-9. PubMed ID: 5146576 [No Abstract] [Full Text] [Related]
31. Current aspects of tumor immunology. Preface and introduction. Weiss DW Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649 [No Abstract] [Full Text] [Related]
32. The optimal technological approach to the development of human hybridomas. Dorfman NA J Biol Response Mod; 1985 Jun; 4(3):213-39. PubMed ID: 2991473 [No Abstract] [Full Text] [Related]
33. Manipulation of host resistance in cancer therapy. Baldwin RW Springer Semin Immunopathol; 1982; 5(2):113-25. PubMed ID: 6755781 [No Abstract] [Full Text] [Related]
34. A prospect on cancer immunology. Kobayashi H Hokkaido Igaku Zasshi; 1979 Nov; 54(6):549-77. PubMed ID: 397163 [TBL] [Abstract][Full Text] [Related]
35. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy. Seremet T; Brasseur F; Coulie PG Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282 [TBL] [Abstract][Full Text] [Related]
36. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft. Zola H Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711 [TBL] [Abstract][Full Text] [Related]
37. [The immunotherapeutic approaches to the management of leukemia and neoplasms]. Leu TP Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699 [No Abstract] [Full Text] [Related]
38. Immunotherapy of malignancy in humans. Current status. Holmes EC; Eilber FR; Morton DL JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402 [TBL] [Abstract][Full Text] [Related]